Summary
Accumulating evidence has demonstrated that aberration of the p53 tumour-suppressor gene is one of the pivotal genetic events in hepatocellular carcinogenesis. Recent reports suggest that the product of hepatitis B virus (HBV) interacts with p53 and that the hepatitis C virus (HCV) core protein reduces p53 expression. A novel p73 gene, which is related to p53, has recently been identified and mapped to chromosome 1p36.3, which is a locus of multiple tumour-suppressor genes for many cancers, including hepatocellular carcinoma (HCC) and neuroblastoma. Here, we investigated mRNA expression, allelotype and mutation of p73 in 48 HCCs obtained from untreated patients. Reverse transcriptase polymerase chain reaction (RT-PCR) revealed that p73 mRNA was expressed ubiquitously at low levels in all the tumour tissues, as well as in the adjacent normal liver tissues. The frequency of p73 loss of heterozygosity was observed in 20% of HCCs, but PCR-single strand conformation polymorphism (SSCP) analysis showed no mutations in the 48 tumours except for three types of polymorphisms. These results suggest that p73 may play a role in hepatocellular carcinogenesis in a different manner from a Knudson two-hit model. The regulatory mechanism of interaction between p73 and hepatitis viruses remains to be determined.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bressac, B., Kew, M., Wands, J. & Ozturk, M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429–431
Buetow, K. H., Murray, J. C., Israel, J. L., London, W. T., Smith, M., Kew, M., Blanquet, V., Brechot, C., Redeker, A. & Govindarajah, S. (1989). Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852–8856
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159
Coursaget, P., Depril, N., Chabaud, M., Nandi, R., Mayelo, V., LeCann, P. & Yvonnet, B. (1993). High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 67: 1395–1397
Ding, S. F., Habib, N. A., Dooley, J., Wood, C., Bowles, L. & Delhanty, D. A. (1991). Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis. Br J Cancer 64: 1083–1087
Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K. & Nakamura, Y. (1991). Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89–93
Henkler, F., Waseem, N., Golding, M. H. C., Alison, M. R. & Koshy, R. (1995). Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res 55: 6084–6091
Honda, K., Sbisa, E., Tullo, A., Papeo, P. A., Saccone, C., Poole, S., Pignatelli, M., Mistry, R. R., Ding, S., Isla, A., Davis, A. & Habib, N. A. (1998). p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumor ablation. Br J Cancer 77: 776–782
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J. & Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 350: 427–428
Jost, C. A., Marin, M. C. & Kaelin, W. G. (1997). p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191–194
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F. & Caput, D. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819
Kazachkov, Y., Khaoustov, V., Yoffe, B., Solomon, H., Klintmalm, G. B. G. & Tabor, E. (1996). p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis 17: 2207–2212
Knudson, A. G. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823
Kress, S., Jahn, U. R., Buchmann, A., Bannasch, P. & Schwarz, M. (1992). p53 mutation in human hepatocellular carcinomas from Germany. Cancer Res 52: 3220–3223
Kuroki, T., Fujiwara, Y., Tsuchiya, E., Nakamori, S., Imaoka, S., Knematsu, T., Nakamura, Y. (1995). Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chrom Cancer 13: 163–167
Levine, A. J., Momand, J. & Findlay, C. A. (1991). The p53 tumor suppressor gene. Nature 351: 453–456
Lunn, R. M., Zhang, Y. J., Wang, L. Y., Chen, C. J., Lee, P. H., Lee, C. S., Tsai, W. Y. & Santella, R. M. (1997). p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 57: 3471–3477
Möröy, T., Marchio, A., Etiemble, J., Trepo, C., Tiollais, P. & Buendia, M. A. (1986). Rearrangement and enhanced expression of c- myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 324: 276–279
Murakami, Y., Hayashi, K. & Sekiya, T. (1991). Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res 51: 3356–3361
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A. & Dejean, A. (1997). Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927–2933
Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y-M & Nakagawara, A. (1998). p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H. & Ishizaki, K. (1993). Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53: 368–372
Piao, Z., Kim, H., Jeon, B. K., Lee, W. J. & Park, C. (1997). Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma. Cancer 80: 865–872
Ray, R. B., Steele, R., Meyer, K. & Ray, R. (1997). Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272: 10983–10986
Simon, D., Knowles, B. B. & Weith, A. (1991). Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6: 765–770
Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K. & Maeda, S. (1994). p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54: 231–235
Tsuda, H., Zhang, W., Shimosato, Y., Yokota, J., Terada, M., Sugimura, T., Miyamura, T. & Hirohashi, S. (1990). Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791–6794
Vesey, D. A., Hayward, N. K. & Cooksley, W. G. E. (1994). p53 gene in hepatocellular carcinoma from Australia. Cancer Detect Prev 18: 123–130
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. & Bos, J. L. (1988). Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532
Wang, X. W., Gibson, M. K., Vermeulen, W., Yeh, H., Forrester, K., Stürzbecher, H. W., Hoeijmakers, J. H. J. & Harris, C. C. (1995). Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55: 6012–6016
Yeh, S. H., Chen, P. J., Chen, H. L., Lai, M. Y., Wang, C. C. & Chen, D. S. (1994). Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinoma. Cancer Res 54: 4188–4192
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Mihara, M., Nimura, Y., Ichimiya, S. et al. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br J Cancer 79, 164–167 (1999). https://doi.org/10.1038/sj.bjc.6690027
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690027
Keywords
This article is cited by
-
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA
Nature Cell Biology (2010)
-
p73 can suppress the proliferation of cells that express mutant p53
Oncogene (2003)
-
p73: Friend or foe in tumorigenesis
Nature Reviews Cancer (2002)
-
The Human p73 Promoter: Characterization and Identification of Functional E2F Binding Sites
Neoplasia (2002)
-
Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells
Oncogene (2001)